Clin2
NCT07712614Possibly a fitNot yet recruiting

Comparing a medication app versus pharmacy records for GERD

GERD (Gastroesophageal Reflux Disease)

Part of Digestive system clinical trials.

This trial tests whether a smartphone app can help people with GERD or erosive esophagitis stick to their medicine better than just using the pharmacy records. You might join if you already take a daily proton pump inhibitor (like omeprazole or pantoprazole) and want to use an app for 90 days.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 21 years or older.
  • You have GERD or erosive esophagitis, confirmed by your doctor.
  • You have been taking a daily proton pump inhibitor (PPI) for at least 30 days before joining.
  • You can fill your PPI prescription only at TidalHealth Community Pharmacy for 90 days.
  • You own a smartphone (iPhone or Android) that can run the FORTISKAP™ app.
  • You can understand and follow study instructions in English.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07127276Not yet recruiting
Smartphone app to help GERD patients take medications

This trial tests whether a smartphone app called GERDCare can help people with GERD stick to their medication. It may be a good option if you have typical GERD symptoms like heartburn or regurgitation and are comfortable using a phone app.

Hanoi
NCT07125521Recruiting
Smartphone app study for GERD medication adherence

This study tests whether using a smartphone app called GERDCare helps people with GERD take their medications as prescribed. It may be a good fit if you have typical GERD symptoms like heartburn or regurgitation and are comfortable using a smartphone app.

Hanoi
NCT06613438Recruiting
New wearable device for GERD symptoms

This study tests a new wearable device (eGERD) that aims to reduce symptoms of GERD (heartburn and regurgitation). The trial will check if the device is safe and works well without needing medication.

Chicago, Illinois
NCT07624383Recruiting
New topical treatment for nonerosive acid reflux disease

This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.

Warsaw, Masovian Voivodeship
NCT07613216Not yet recruiting
Testing a medication reminder app for lung and heart conditions

This study compares a smartphone app called FORTISKAP™ that reminds you to take your medications versus standard care. The trial includes people with interstitial lung disease (a scarring condition of the lungs), sarcoidosis (an inflammatory condition), or pulmonary hypertension (high blood pressure in the lungs), and aims to see if the app helps people take their medications more reliably.

Norfolk, Virginia
NCT05900687Not yet recruiting
Testing phone prompts for heartburn and reflux symptoms

This trial tests a mobile phone question list (short prompts) to help track symptoms in people with gastroesophageal reflux disease (GERD). If you qualify, using the prompts may help researchers better understand symptoms and how GERD affects daily life.

Stanford, California

Hear when a new GERD (Gastroesophageal Reflux Disease) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.